AHR and neoplasm: To further ensure that the observed immunological differences were not driven by clinical or demographic imbalances, we compared the tumor stage (T, N, M), histological grade (G), age, sex, and serum CA 19–9 levels between the Low and High/Medium AHR expression groups.